文献速递母胎医学产科

产前诊断中致病性拷贝数变异的特征与遗传模式

Characteristics and mode of inheritance of pathogenic copy number variants in prenatal diagnosis.
PubMed 文献 · Am J Obstet Gynecol · 2019-06-14

该回顾性研究分析1510例接受染色体微阵列分析产前诊断孕妇,并结合文献汇总23865例胎儿数据,发现1.6%胎儿携带致病性拷贝数变异,其中11.7%涉及2个及以上变异,84.1%小于5 Mb,65.6%为新发变异;高危组发生率为1/36,低危组为1/125。

要点

  • 致病性拷贝数变异在妊娠中常见,总体发生率为1.6%。
  • 高危妊娠建议提供染色体微阵列分析的侵入性检测以全面评估。
  • 扩展无创产前筛查前需考虑片段大小、亲源遗传和基因组分布等检测局限。

核心结论

  • 致病性拷贝数变异在妊娠中常见,高危妊娠应提供染色体微阵列分析的侵入性检测以进行全面评估,扩展无创产前筛查前需仔细考虑片段大小、亲源遗传和基因组分布的检测局限。

研究设计与样本

  • 回顾性研究,对1510例接受侵入性产前诊断的孕妇行染色体微阵列分析,并结合文献汇总23865例胎儿数据。

主要发现

  • 23865例胎儿中375例(1.6%)携带致病性拷贝数变异,其中44例(11.7%)涉及2个及以上变异。
  • 共检出428个致病性拷贝数变异,280个为缺失、148个为重复;360个(84.1%)小于5 Mb,68个(15.9%)在5–10 Mb之间。
  • 高危组携带致病性拷贝数变异的发生率为1/36,低危组为1/125。
  • 311个致病性拷贝数变异有亲源遗传结果,其中71个(22.8%)母源遗传、36个(11.6%)父源遗传、204个(65.6%)为新发。

关键数值与推荐

  • 高危妊娠应提供染色体微阵列分析的侵入性检测以进行全面评估。
  • 扩展无创产前筛查实施拷贝数变异筛查前,应仔细考虑片段大小、亲源遗传和基因组分布的检测局限。

临床怎么用

  • 高危妊娠应提供染色体微阵列分析的侵入性检测以进行全面评估。
  • 扩展无创产前筛查前需仔细考虑片段大小、亲源遗传和基因组分布的检测局限。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Microdeletions and microduplications can occur in any pregnancy independent of maternal age. The spectrum and features of pathogenic copy number variants including the size, genomic distribution, and mode of inheritance are not well studied. These characteristics have important clinical implications regarding expanding noninvasive prenatal screening for microdeletions and microduplications. OBJECTIVES: The aim was to investigate the spectrum and characteristics of pathogenic copy number variants in prenatal genetic diagnosis and to provide recommendations for expanding the scope of noninvasive prenatal screening for microdeletions and microduplications. STUDY DESIGN: This was a retrospective study of 1510 pregnant women who underwent invasive prenatal diagnostic testing by chromosomal microarray analysis. Prenatal samples were retrieved by amniocentesis or chorionic villus sampling and sent to our prenatal genetic diagnosis laboratory for chromosomal microarray analysis. The risk of carrying a fetus with pathogenic copy number variants is stratified by the patients' primary indication for invasive testing. We searched the literature for published prenatal chromosomal microarray data to generate a large cohort of 23,865 fetuses. The characteristics and spectrum of pathogenic copy number variants including the type of aberrations (gains or losses), genomic loci, sizes, and the mode of inheritance were studied. RESULTS: Overall, 375 of 23,865 fetuses (1.6%) carried pathogenic copy number variants for any indication for invasive testing, and 44 of them (11.7%) involve 2 or more pathogenic copy number variants. A total of 428 pathogenic copy number variants were detected in these fetuses, of which 280 were deletions and 148 were duplications. Three hundred sixty (84.1%) were less than 5 Mb in size and 68 (15.9%) were between 5 and 10 Mb. The incidence of carrying a pathogenic copy number variant in the high-risk group is 1 in 36 and the low-risk group is 1 in 125. Parental inheritance study results were available for 311 pathogenic copy number variants, 71 (22.8%) were maternally inherited, 36 (11.6%) were paternally inherited, and 204 (65.6%) occurred de novo. CONCLUSION: Collectively, pathogenic copy number variants are common in pregnancies. High-risk pregnancies should be offered invasive testing with chromosomal microarray analysis for the most comprehensive investigation. Detection limits on size, parental inheritance, and genomic distribution should be carefully considered before implementing copy number variant screening in expanded noninvasive prenatal screening.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Chau MHK, Cao Y, Kwok YKY, et al. Characteristics and mode of inheritance of pathogenic copy number variants in prenatal diagnosis. Am J Obstet Gynecol. 2019. PMID: 31207233. doi:10.1016/j.ajog.2019.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。